SCIB

FDA expert panel in line with SciBase position to keep stringent approval level for all new skin lesion analyzers

Retrieved on: 
Tuesday, August 9, 2022 - 7:18am

Panel members urged caution for skin cancer detection SLAs and Apps and stressed the need for more high quality research to validate these technologies.

Key Points: 
  • Panel members urged caution for skin cancer detection SLAs and Apps and stressed the need for more high quality research to validate these technologies.
  • The Panel underscored the potential risks of reclassifying these technologies and strongly recommended keeping them in the class III category.
  • SciBase shared the same opinion as panel experts through written submissions and oral presentations.
  • SciBase believes the current process where FDA sets very high standards and is closely involved in clinical validation study design is the most appropriate.

Sarawak Consolidated Industries Berhad Signs MoU for Indonesian 4G Telco Tower Project

Retrieved on: 
Wednesday, August 3, 2022 - 6:30am

KUCHING, MALAYSIA, Aug 3, 2022 - (ACN Newswire) - Civil engineering specialist Sarawak Consolidated Industries Berhad (SCIB) has entered into a Memorandum of Understanding (MoU) with PT.

Key Points: 
  • KUCHING, MALAYSIA, Aug 3, 2022 - (ACN Newswire) - Civil engineering specialist Sarawak Consolidated Industries Berhad (SCIB) has entered into a Memorandum of Understanding (MoU) with PT.
  • Envy Manajemen Konsultansi (EMK) to explore the formation of a partnership in relation to the construction of 4G telecommunications towers for Indonesia's outermost regions.
  • Under the MoU, SCIB will anchor the formation of the partnership as well as providing the corporate management setup.
  • EMK, which is involved in business advisory, consultation, project management and other corporate management activities, will provide project management services through operational and technical supervision.

Banco Santander-Chile Announces Second Quarter 2022 Earnings

Retrieved on: 
Friday, July 29, 2022 - 12:36pm

SANTIAGO, Chile, July 29, 2022 (GLOBE NEWSWIRE) -- Banco Santander Chile (NYSE: BSAC; SSE: Bsantander) announced today its resultsi for the six-month period ended June 30, 2022 and second quarter 2022 (2Q22).

Key Points: 
  • SANTIAGO, Chile, July 29, 2022 (GLOBE NEWSWIRE) -- Banco Santander Chile (NYSE: BSAC; SSE: Bsantander) announced today its resultsi for the six-month period ended June 30, 2022 and second quarter 2022 (2Q22).
  • With these results, the Bank notched its sixth consecutive quarter of plus 20% ROAE which reached 31.7% in 2Q22.
  • The total number of Life clients as of June 2022 increased 42.0% YoY and in the second quarter 2022 Life opened 59,366 current accounts reaching a total of 1,035,984 clients.
  • This led to the quarterly decrease in our capital ratios from 10.4% in March 2022 to 9.6% as of June 30, 2022.

BANCO SANTANDER MÉXICO ANNOUNCES STRUCTURAL CHANGES IN ITS CEO POSITION AND SENIOR MANAGEMENT

Retrieved on: 
Thursday, July 21, 2022 - 9:30pm

Mr. Hctor Grisi will remain as Executive Chairman and Chief Executive Officer of Grupo Financiero Santander Mxico (the "Group") until December 31, 2022.

Key Points: 
  • Mr. Hctor Grisi will remain as Executive Chairman and Chief Executive Officer of Grupo Financiero Santander Mxico (the "Group") until December 31, 2022.
  • ABOUT BANCO SANTANDER MXICO (NYSE: BSMX BMV: BSMX)
    Banco Santander Mxico, S.A., Institucin de Banca Mltiple, Grupo Financiero Santander Mxico (Banco Santander Mxico), one of the leading banks in Mexico, offers a wide range of products and financial services, including retail banking, financial advisory services, as well as other investment activities.
  • Banco Santander Mexico offers a financial services platform focused on the middle and high-income segments of the population as well as small and medium companies.
  • As of March 31, 2022, Banco Santander Mexico held total assets of Ps.1,734 billion pesos and had more than 20.1 million clients.

Sarawak Consolidated Industries Berhad Welcomes New Batch of Trainees for Industrial Training

Retrieved on: 
Wednesday, June 15, 2022 - 5:00am

KUCHING, MALAYSIA, June 15, 2022 - (ACN Newswire) - Sarawak Consolidated Industries Berhad (SCIB), a civil engineering specialist, is pleased to welcome a new batch of trainees from Institut Latihan Perindustrian Kota Samarahan (ILPKS), Sarawak, to the Company for physical training as part of the industrial training programme in their final year.

Key Points: 
  • KUCHING, MALAYSIA, June 15, 2022 - (ACN Newswire) - Sarawak Consolidated Industries Berhad (SCIB), a civil engineering specialist, is pleased to welcome a new batch of trainees from Institut Latihan Perindustrian Kota Samarahan (ILPKS), Sarawak, to the Company for physical training as part of the industrial training programme in their final year.
  • The trainees were accepted into the programme following a Memorandum of Understanding (MoU) signed between the SCIB and ILP Kota Samarahan in October 2020.
  • The MoU gives opportunities for industrial students to undergo training; offers industrial instructors places for industrial attachment training; offer job opportunities to qualified Institut Latihan Jabatan Tenaga Manusia graduates and offers short-term courses to SCIB employees who want to upgrade their skills.
  • "We provide them with a platform to learn and grow, thus giving them better understanding of their craft and the industry.

Sarawak Consolidated Industries Berhad Provides Further Clarification on LOA from Ennova

Retrieved on: 
Monday, June 13, 2022 - 11:00am

Ennova is to bear all construction cost of the poles, including the rental of each erected pole in accordance with the agreed rental price between it and DBKL.

Key Points: 
  • Ennova is to bear all construction cost of the poles, including the rental of each erected pole in accordance with the agreed rental price between it and DBKL.
  • "We are unaware of any funding or financing arrangement for the contract by DBKL.
  • Copyright 2022 ACN Newswire .
  • All rights reserved.

Banco Santander-Chile Announces First Quarter 2022 Earnings

Retrieved on: 
Friday, April 29, 2022 - 12:30pm

SANTIAGO, Chile, April 29, 2022 (GLOBE NEWSWIRE) -- Banco Santander Chile (NYSE: BSAC; SSE: Bsantander) announced today its unaudited resultsi for the three-month period ended March 31, 2022 and first quarter 2022 (1Q22).

Key Points: 
  • SANTIAGO, Chile, April 29, 2022 (GLOBE NEWSWIRE) -- Banco Santander Chile (NYSE: BSAC; SSE: Bsantander) announced today its unaudited resultsi for the three-month period ended March 31, 2022 and first quarter 2022 (1Q22).
  • With these results, the Bank notched its sixth consecutive quarter of plus 20% ROAE which reached 25.6% in 1Q22.
  • The total number of Life clients as of March 2022 increased 59.7% YoY and in the first quarter 2022 Life opened 76,553 current accounts reaching a total of 976,618 clients.
  • Superdigital continues its acceleration in client acquisition with 28,753 new clients in the quarter, reaching a total of 292,474 clients.

SciBase further strengthens patent portfolio

Retrieved on: 
Wednesday, March 30, 2022 - 7:31am

STOCKHOLM, March 30, 2022 /PRNewswire/ --SciBase Holding AB("SciBase") [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today that its patent application : EP Application No.

Key Points: 
  • STOCKHOLM, March 30, 2022 /PRNewswire/ --SciBase Holding AB("SciBase") [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today that its patent application : EP Application No.
  • In addition, SciBase was granted their first patent within the skin barrier area in Sweden in November.
  • This patent named `Epithelial barrier function' with application no 1851376-2, was granted by the Swedish patent authority and is seen as a positive indication that an EPO patent will also eventually be granted.
  • The Swedish patent is also an important stepin the processtowardsan EPO patent for the barrier application", says Simon Grant CEO SciBase.

SciBase Barrier technology part of major immunodermatology project

Retrieved on: 
Wednesday, March 23, 2022 - 2:08pm

NGID is a nationwide, large-scale project to unravel novel biomarkers for six different skin diseases.

Key Points: 
  • NGID is a nationwide, large-scale project to unravel novel biomarkers for six different skin diseases.
  • The importance of the skin barrier in diseases such as atopic dermatitis is well known, but until now it has not been possible to evaluate the barrier in routine clinical practice.
  • The inclusion of these SciBase products in this consortium is a testament to the robust diagnostic potential of the SciBase technology.
  • The opportunity for SciBase is to become an integral part of personalized atopic dermatitis management, and with the very high numbers of patients affected, this is one of the most significant opportunities for SciBase to date", says Simon Grant CEO SciBase.

Article on consequences of MDR regulation within Dermatology published in JEADV

Retrieved on: 
Monday, November 29, 2021 - 8:05am

STOCKHOLM, Nov. 29, 2021 /PRNewswire/ --SciBase Holding AB ("SciBase") [STO: SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today, that an article describing the consequences of the new medical device regulation (MDR) in the EU has been published in the journal "Journal of the European Academy of Dermatology and Venereology" (JEADV).

Key Points: 
  • STOCKHOLM, Nov. 29, 2021 /PRNewswire/ --SciBase Holding AB ("SciBase") [STO: SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today, that an article describing the consequences of the new medical device regulation (MDR) in the EU has been published in the journal "Journal of the European Academy of Dermatology and Venereology" (JEADV).
  • The new MDR regulation that came into force on May 26 2021 will have significant effects for the medical device industry and for clinicians, including Dermatologists.
  • SciBase is one of very few companies in the field of dermatology that is certified according to the new more stringent MDR regulation.
  • says Simon Grant, CEO of SciBase
    The article was a collaboration between Dermatology clinicians and regulatory experts with input from SciBase and can be found at the JEADV journals homepage: https://onlinelibrary.wiley.com/doi/abs/10.1111/jdv.17830
    For more information please contact: